BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37066)

  • 1. Bromocriptine in the treatment of parkinsonism.
    Parkes JD
    Drugs; 1979 May; 17(5):365-82. PubMed ID: 37066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Considerations in the drug treatment of parkinsonism (author's transl)].
    Hungerbühler JP; Regli F
    Schweiz Rundsch Med Prax; 1978 Nov; 67(45):1648-57. PubMed ID: 30976
    [No Abstract]   [Full Text] [Related]  

  • 3. [New directions in contemporary pharmacotherapy of parkinsonism (review)].
    Kurako IuL; Volianskiĭ VE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1401-6. PubMed ID: 6150591
    [No Abstract]   [Full Text] [Related]  

  • 4. Apomorphine and piribedil in rats: biochemical and pharmacologic studies.
    Butterworth RF; Poignant JC; Barbeau A
    Adv Neurol; 1975; 9():307-26. PubMed ID: 1170716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ergot derivatives for Parkinsonism.
    Calne DB; Williams AC; Nutt JG; Neophytides A; Eisler T; Teychenne PF
    Med J Aust; 1978 Nov; 2(3 Suppl):25-6. PubMed ID: 34083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of parkinsonism with dopaminergic system agonists].
    Dowzenko A
    Neurol Neurochir Pol; 1976; 10(4):579-82. PubMed ID: 958587
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of parkinson's disease with bromocriptine.
    Lieberman A; Kupersmith M; Estey E; Goldstein M
    N Engl J Med; 1976 Dec; 295(25):1400-4. PubMed ID: 989885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term use of dopamine agonists in Parkinson's disease.
    Jankovic J
    Clin Neuropharmacol; 1985; 8(2):131-40. PubMed ID: 3891082
    [No Abstract]   [Full Text] [Related]  

  • 9. Developments in the treatment of parkinsonism.
    Calne DB
    N Engl J Med; 1976 Dec; 295(25):1433-4. PubMed ID: 989886
    [No Abstract]   [Full Text] [Related]  

  • 10. Dopamine receptor stimulating agonists in the treatment of Parkinson's disease.
    Agid Y; Barroche G; Bonnet AM; Javoy-Agid F; Kato G; Lhermitte F; Pollak P; Signoret JL
    Biomedicine; 1979 Jun; 30(2):67-71. PubMed ID: 383169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.
    Parkes JD; Debono AG; Marsden CD
    J Neurol Neurosurg Psychiatry; 1976 Nov; 39(11):1101-8. PubMed ID: 1036999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies with bromocriptine. Part 1. "On-off" phenomena.
    Kartznel R; Calne DB
    Neurology; 1976 Jun; 26(6 PT 1):508-10. PubMed ID: 945489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bromocriptine-induced behavioral hypersensitivity: implications for the therapy of parkinsonism.
    Nausieda PA; Weiner WJ; Kanapa DJ; Klawans HL
    Neurology; 1978 Nov; 28(11):1183-8. PubMed ID: 568738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: Bromocriptine in parkinsonism.
    Debono AG; Donaldson I; Marsden CD; Parkes JD
    Lancet; 1975 Nov; 2(7942):987-8. PubMed ID: 53479
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison between lergotrile and bromocriptine in parkinsonism.
    Teychenne PF; Pfeiffer RF; Bern SM; McInturff D; Calne DB
    Ann Neurol; 1978 Apr; 3(4):319-24. PubMed ID: 666273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical studies with bromocriptine in idiopathic parkinsonism.
    Teychenne PF; Kartzinel R; Perlow M; Pfeiffer R; Calne DB
    Trans Am Neurol Assoc; 1976; 101():302-4. PubMed ID: 1037483
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of parkinsonism with bromocriptine.
    Calne DB; Teychenne PF; Leigh PN; Bamji AN; Greenacre JK
    Lancet; 1974 Dec; 2(7893):1355-6. PubMed ID: 4143315
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: Bromocriptine in parkinsonism.
    Lees AJ; Shaw KM; Stern GM
    Lancet; 1975 Oct; 2(7937):709-10. PubMed ID: 52084
    [No Abstract]   [Full Text] [Related]  

  • 19. Double-blind comparison of cabergoline and bromocriptine in Parkinson's disease patients with motor fluctuations.
    Inzelberg R; Nisipeanu P; Rabey JM; Orlov E; Catz T; Kippervasser S; Schechtman E; Korczyn AD
    Neurology; 1996 Sep; 47(3):785-8. PubMed ID: 8797480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain dopamine turnover and the relief of parkinsonism.
    Rinne UK; Sonninen V; Marttila R
    Adv Exp Med Biol; 1977; 90():267-75. PubMed ID: 930747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.